United States· US:50242-100_71192c41-f7be-44b0-b232-1f74369239a0
Pulmozyme
A dornase alfa product containing dornase alfa, registered in United States by Genentech, Inc.. The same ATC class is registered in 3 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Dornase alfa is registered in 3 of 19 countries.
Countries holding a registration under ATC DORNASE ALFA (dornase alfa), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 1 of them publish a price we can compare per daily dose
Dornase alfa · ATC DORNASE ALFA
3 / 19 countries
- Germany
- United Kingdom
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- DORNASE ALFA
- Manufacturer
- Genentech, Inc.
- Country
- United States (US)
- ATC code
- DORNASE ALFA
- ATC class
- DORNASE ALFA
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc1150242-100-40
- ndc1150242100405 POUCH in 1 CARTON (50242-100-40) / 6 AMPULE in 1 POUCH (50242-100-39) / 2.5 mL in 1 AMPULE
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Dornase alfa in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwedenPulmozyme 1 mg/ml Lösning för nebulisatorMedartuum AB
- FinlandPulmozymeRoche Oy
- IcelandPulmozymeRoche Pharmaceuticals A/S
- NetherlandsPulmozyme, inhalatievloeistof 1 mg/ml, 2,5 mlEU-Pharma B.V.
- NorwayPulmozymeRoche Norge AS
- PolandPulmozymeRoche Polska Sp. z o.o.
- United KingdomPulmozyme 2.5mg nebuliser liquid 2.5ml ampoulesWaymade Healthcare Plc
- IrelandPulmozyme 2500 U/ 2.5ml, nebuliser solutionRoche Products (Ireland) Limited
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Pulmozyme
- Belgium · Pulmozyme
- Bulgaria · Пулмозим
- Cyprus · Pulmozyme
- Czechia · Pulmozyme
- Germany · Pulmozyme
- Denmark · Pulmozyme
- Estonia · Pulmozyme
- Spain · Pulmozyme
- Finland · Pulmozyme
- France · Pulmozyme
- United Kingdom (Northern Ireland) · Pulmozyme
- Greece · Pulmozyme
- Croatia · Pulmozyme Otopina Za Atomizator
- Hungary · Pulmozyme
- Ireland · Pulmozyme
- Iceland · Pulmozyme
- Italy · Pulmozyme
- Lithuania · Pulmozyme
- Luxembourg · Pulmozyme
- Latvia · Pulmozyme
- Netherlands · Pulmozyme Verneveloplossing
- Norway · Pulmozyme
- Poland · Pulmozyme
- Portugal · Pulmozyme
- Romania · Pulmozyme
- Sweden · Pulmozyme
- Slovenia · Pulmozyme
- Slovakia · Pulmozyme
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f9e0512e-bb9b-4ef9-82fb-4315e1966122 GET /v1/drugs/f9e0512e-bb9b-4ef9-82fb-4315e1966122?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "RESPIRATORY (INHALATION)",
"source": "ndc",
"strength": "1",
"substance": "DORNASE ALFA",
"productndc": "50242-100",
"dosage_form": "SOLUTION",
"dea_schedule": null,
"strength_unit": "mg/mL",
"application_number": "BLA103532",
"marketing_category": "BLA"
}See everything about dornase alfa.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.